Response.
Department of Surgery, Keio University School of Medicine, Tokyo, Japan (AN, TH, HJ, MT, YK).
Aiko
A
Nagayama
Department of Surgery, Keio University School of Medicine, Tokyo, Japan (AN, TH, HJ, MT, YK). tetsu@z7.keio.jp.
Tetsu
T
Hayashida
Department of Surgery, Keio University School of Medicine, Tokyo, Japan (AN, TH, HJ, MT, YK).
Hiromitsu
H
Jinno
Department of Surgery, Keio University School of Medicine, Tokyo, Japan (AN, TH, HJ, MT, YK).
Maiko
M
Takahashi
Department of Surgery, Keio University School of Medicine, Tokyo, Japan (AN, TH, HJ, MT, YK).
Yuko
Y
Kitagawa
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy / Q000379:methods*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors*
D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases